R&D

Problem

Cataracts is a clouding and hardening of the lens in the eye leading to a decrease in vision. Cataracts is the cause of half of blindness and 33% of visual impairment worldwide. The treatment of cataracts is a surgery that replaces the natural lens with an artificial lens called an Intraocular lens (IOL).  It is also the most common performed out-patient surgery in the world with over 32 million estimated by 2020.  

Presbyopia affects over 25% of the world’s population and is due to the natural aging of the eye, specifically the lens apparatus.  It usually begins to occur at around age 40, and is the inability to focus up close. In order to see close-up objects, our eyes have to accommodate. The lens apparatus of the eye becomes stiff, less elastic as we age, making it more difficult for the lens to change shape, essentially to contract / relax in order to focus.

Technology

Surprisingly, innovation in IOL design has not changed significantly over the last 20 years. At MAG, we recognize the limitations of current IOL technology and incorporated latest research around accommodation theory.

MAG’s dual-optic accommodative IOL design incorporates the learnings from previous industry designs and challenges, but more importantly, encompass our novel approach to solving for one of most biological challenges in medicine – restoring accommodation in the eye, thus provides a solution for presbyopia. Our proprietary technology is unique because: 

 

• It has been designed to specifically address the inevitable challenges of the anatomy and reoccurring fibrosis.

• It provides customization during interoperability.

• It leverages the natural forces in the eye to prevent PCO.

• It aligns with industry surgical standards for incision size.

 

One of ophthalmology’s most challenging problem remains how to restore accommodation in an eye with an IOL and presbyopia, we believe that MAG’s accommodative IOL provides the solution.